Safety and Tolerability of Glatiramer Acetate (GLACIER)
Study Title
- Safety and Tolerability of Glatiramer Acetate
Teva Identifier
- GA-MS-303
ClinicalTrials.gov Identifier
- NCT01874145
Study Status
- Completed
Trial Condition(s)
- Relapsing-Remitting Multiple Sclerosis
Interventions
- Drug: GA 20 mg/mL | Drug: GA 40 mg/mL
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- 06/01/2013 - 05/01/2014
Phase
- Phase 3
Study Type
Interventional
